HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Andersen-Tawil syndrome: a model of clinical variability, pleiotropy, and genetic heterogeneity.

Abstract
Due to its varied and variable phenotypes, Andersen-Tawil syndrome (ATS) holds a unique place in the field of channelopathies. Patients with ATS typically present with the triad of periodic paralysis, cardiac arrhythmias, and developmental dysmorphisms. Although penetrance of ATS is high, disease expression and severity are remarkably variable. Mutations in KCNJ2 are the primary cause of ATS with 21 mutations discovered in 30 families. These mutations affect channel function through heterogeneous mechanisms, including reduced PIP2-related channel activation and altered pore function. Aside from KCNJ2-based ATS, the genetic basis of this disease in nearly 40% of cases is unknown. Other ATS genes likely share a common pathway or function with Kir2.1 or facilitate the activity of this ion channel. In this review, we explore hypotheses explaining the pathogenesis, expression, and variability of ATS.
AuthorsMatthew R Donaldson, Grace Yoon, Ying-Hui Fu, Louis J Ptacek
JournalAnnals of medicine (Ann Med) Vol. 36 Suppl 1 Pg. 92-7 ( 2004) ISSN: 0785-3890 [Print] England
PMID15176430 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S., Review)
Chemical References
  • Potassium Channels, Inwardly Rectifying
Topics
  • Arrhythmias, Cardiac (genetics, physiopathology)
  • Genetic Heterogeneity
  • Humans
  • Long QT Syndrome (genetics, physiopathology)
  • Mutation
  • Paralysis, Hyperkalemic Periodic (genetics, physiopathology)
  • Potassium Channels, Inwardly Rectifying (genetics, physiology)
  • Syndrome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: